Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase III Study Comparing Neoadjuvant Chemotherapy With Carboplatin and Paclitaxel Followed by Standard Therapy, With Standard Therapy Alone in Women With Cervical Cancer and Para Aortic Positive Lymph Node.

NCT03534713 is registered in ClinicalTrials.gov with University Hospital, Toulouse as lead sponsor.

NCT NCT03534713
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03534713 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase III Study Comparing Neoadjuvant Chemotherapy With Carboplatin and Paclitaxel Followed by Standard Therapy, With Standard Therapy Alone in Women With Cervical Cancer and Para Aortic Positive Lymph Node.
Lead sponsor
University Hospital, Toulouse
Phase
Phase 3
Overall status
Recruiting
Start date
July 17, 2020
Completion date
December 31, 2026
Enrollment
310 (estimated)
Sites
11

Conditions

As the registry lists them; a condition with its own page is linked.

cervical cancer tnm staging regional lymph nodes (n)